325% return in 5 years: This multibagger stock in focus after H2 FY2025 results
Stock market news: There are stocks that have given multibagger returns to their investors. One such stock is of small-cap pharma company, Sudarshan Pharma Industries Ltd. The company’s share price is in focus today during the trading session. The reason for this is that the company has announced its March quarter and FY 2025 results on Friday. Multibagger Pharma Stock closed at Rs 26.66 on May 2 with a decline of 1.99 per cent. The stock opened flat today but surged to hit the intraday high of Rs 27.99 on the BSE.
Sudarshan Pharma Industries shares have given more than 325 per cent return in 5 years.
In the second half of FY 2025, i.e. October 2024 to March 2025 (H2FY25), net sales of Sudarshan Pharma Industries Limited increased by 19 per cent to Rs 277 crore as compared to the same period a year ago. Net profit increased by 43 per cent to Rs 7 crore. EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization) margin also saw a good increase in H2FY25.
For the full financial year 2024-25, the company’s net sales grew by 9 per cent to Rs 505 crore, while net profit grew by 45 per cent to Rs 16 crore. The company’s market cap is Rs 642 crore. The company’s compound annual profit growth has been 37 per cent in the last 5 years. India’s pharmaceutical industry was worth around $42 billion in the year 2021. It can reach around $66 billion by 2025, while it can grow to $120-130 billion by 2030. During the March 2025 quarter, the company’s revenue from operations grew 16.6 per cent year-on-year to Rs 277.26 crore from Rs 237.74 crore in the March 2024 quarter.
Sudarshan Pharma Industries has reported a net profit of Rs 10.03 crore during the quarter ended March 31, 2025. This profit is about 52 per cent higher than the net profit of Rs 6.64 crore recorded during the quarter ended March 31, 2024.
The pharma company told its investors that SPIL is working on boosting its exports. Along with this, it is actively working to increase domestic sales of its manufactured medicines. Apart from this, the company aims to improve profit margins by reselling active pharmaceutical ingredients (APIs) in India. Let us tell you that Sudarshan Pharma Industries manufactures specialty chemicals and intermediates for pharma, agro chemicals, paints, adhesives and other industries.
News